Skip to main content
Erschienen in: Cellular Oncology 5/2017

22.06.2017 | Original Paper

Crosstalk between M2 macrophages and glioma stem cells

verfasst von: Leora M. Nusblat, Molly J. Carroll, Charles M. Roth

Erschienen in: Cellular Oncology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Given its extremely poor prognosis, there is a pressing need for an improved understanding of the biology of glioblastoma multiforme (GBM), including the roles of tumor subpopulations that may contribute to their growth rate and therapy resistance. The most malignant phenotypes of GBM have been ascribed to the presence of subpopulations of cancer stem cells (CSCs), which are resistant to chemotherapeutic drugs and ionizing radiation and which promote invasiveness and metastasis. The mechanisms by which the CSC state is obtained and by which it promotes tumor maintenance are only beginning to emerge. We hypothesize that M2 polarized macrophages may affect CSC phenotypes via cell-cell communication.

Methods

We investigated the interplay between glioma CSCs and macrophages via co-culture. The invasiveness of CSCs in the absence and presence of macrophages was assessed using collagen degradation and Transwell migration assays. The role of STAT3 as a CSC phenotypic mediator was assessed using siRNA-mediated gene silencing.

Results

We found that the levels of a M2 macrophage-specific secreted cytokine, TGF-β1, were elevated in the presence of CSCs, regardless of whether the cells were plated as contacting or non-contacting co-cultures. In addition, we found that the co-culture resulted in enhanced expression of M2 markers in macrophages that were previously polarized to the M1 phenotype. siRNA-mediated STAT3 silencing was found to reduce the chemo-responsiveness and migratory abilities of the CSCs. Combination treatment of STAT3 siRNA and DNA alkylating agents was found to further abrogate CSC functions.

Conclusions

Our data indicate that the co-culture of CSCs and macrophages results in bi-directional signaling that alters the phenotypes of both cell types. These results provide an explanation for recently observed effects of macrophages on GBM tumor cell growth, motility and therapeutic resistance, and suggest potential therapeutic strategies to disrupt the CSC phenotype by impairing its communication with macrophages.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Z. Li, J.W. Lee, D. Mukherjee, J. Ji, S.P. Jeswani, K.L. Black, J.S. Yu, Immunotherapy targeting glioma stem cells--insights and perspectives. Expert. Opin. Biol. Ther. 12, 165–178 (2012)CrossRefPubMed Z. Li, J.W. Lee, D. Mukherjee, J. Ji, S.P. Jeswani, K.L. Black, J.S. Yu, Immunotherapy targeting glioma stem cells--insights and perspectives. Expert. Opin. Biol. Ther. 12, 165–178 (2012)CrossRefPubMed
2.
Zurück zum Zitat M. Staberg, S.R. Michaelsen, R.D. Rasmussen, M. Villingshoj, H.S. Poulsen, P. Hamerlik, Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine. Cell. Oncol. 40, 21–32 (2017) M. Staberg, S.R. Michaelsen, R.D. Rasmussen, M. Villingshoj, H.S. Poulsen, P. Hamerlik, Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine. Cell. Oncol. 40, 21–32 (2017)
3.
Zurück zum Zitat D. Matias, J. Balca-Silva, L.G. Dubois, B. Pontes, V.P. Ferrer, L. Rosario, A. do Carmo, J. Echevarria-Lima, A.B. Sarmento-Ribeiro, M.C. Lopes, V. Moura-Neto, Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition. Cell. Oncol. 40, 247–261 (2017) D. Matias, J. Balca-Silva, L.G. Dubois, B. Pontes, V.P. Ferrer, L. Rosario, A. do Carmo, J. Echevarria-Lima, A.B. Sarmento-Ribeiro, M.C. Lopes, V. Moura-Neto, Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition. Cell. Oncol. 40, 247–261 (2017)
4.
Zurück zum Zitat H.D. Hemmati, I. Nakano, J.A. Lazareff, M. Masterman-Smith, D.H. Geschwind, M. Bronner-Fraser, H.I. Kornblum, Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U. S. A. 100, 15178–15183 (2003)CrossRefPubMedPubMedCentral H.D. Hemmati, I. Nakano, J.A. Lazareff, M. Masterman-Smith, D.H. Geschwind, M. Bronner-Fraser, H.I. Kornblum, Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U. S. A. 100, 15178–15183 (2003)CrossRefPubMedPubMedCentral
5.
6.
Zurück zum Zitat A. Chavez-Gonzalez, B. Bakhshinejad, K. Pakravan, M.L. Guzman, S. Babashah, Novel strategies for targeting leukemia stem cells: Sounding the death knell for blood cancer. Cell. Oncol. (Dordr.) 40, 1–20 (2017)CrossRef A. Chavez-Gonzalez, B. Bakhshinejad, K. Pakravan, M.L. Guzman, S. Babashah, Novel strategies for targeting leukemia stem cells: Sounding the death knell for blood cancer. Cell. Oncol. (Dordr.) 40, 1–20 (2017)CrossRef
7.
Zurück zum Zitat J.M. Heddleston, M. Hitomi, M. Venere, W.A. Flavahan, K. Yang, Y. Kim, S. Minhas, J.N. Rich, A.B. Hjelmeland, Glioma stem cell maintenance: The role of the microenvironment. Curr. Pharm. Des. 17, 2386–2401 (2011)CrossRefPubMedPubMedCentral J.M. Heddleston, M. Hitomi, M. Venere, W.A. Flavahan, K. Yang, Y. Kim, S. Minhas, J.N. Rich, A.B. Hjelmeland, Glioma stem cell maintenance: The role of the microenvironment. Curr. Pharm. Des. 17, 2386–2401 (2011)CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat J. Kolenda, S.S. Jensen, C. Aaberg-Jessen, K. Christensen, C. Andersen, N. Brunner, B.W. Kristensen, Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids. J. Neuro-Oncol. 103, 43–58 (2011)CrossRef J. Kolenda, S.S. Jensen, C. Aaberg-Jessen, K. Christensen, C. Andersen, N. Brunner, B.W. Kristensen, Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids. J. Neuro-Oncol. 103, 43–58 (2011)CrossRef
9.
Zurück zum Zitat Z. Li, H. Wang, C.E. Eyler, A.B. Hjelmeland, J.N. Rich, Turning cancer stem cells inside out: An exploration of glioma stem cell signaling pathways. J. Biol. Chem. 284, 16705–16709 (2009)CrossRefPubMedPubMedCentral Z. Li, H. Wang, C.E. Eyler, A.B. Hjelmeland, J.N. Rich, Turning cancer stem cells inside out: An exploration of glioma stem cell signaling pathways. J. Biol. Chem. 284, 16705–16709 (2009)CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat R. Wang, K. Chadalavada, J. Wilshire, U. Kowalik, K.E. Hovinga, A. Geber, B. Fligelman, M. Leversha, C. Brennan, V. Tabar, Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468, 829–833 (2010)CrossRefPubMed R. Wang, K. Chadalavada, J. Wilshire, U. Kowalik, K.E. Hovinga, A. Geber, B. Fligelman, M. Leversha, C. Brennan, V. Tabar, Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468, 829–833 (2010)CrossRefPubMed
11.
Zurück zum Zitat M. Prinz, J. Priller, Microglia and brain macrophages in the molecular age: From origin to neuropsychiatric disease. Nat. Rev. Neurosci. 15, 300–312 (2014)CrossRefPubMed M. Prinz, J. Priller, Microglia and brain macrophages in the molecular age: From origin to neuropsychiatric disease. Nat. Rev. Neurosci. 15, 300–312 (2014)CrossRefPubMed
12.
Zurück zum Zitat M.B. Graeber, B.W. Scheithauer, G.W. Kreutzberg, Microglia in brain tumors. Glia 40, 252–259 (2002)CrossRefPubMed M.B. Graeber, B.W. Scheithauer, G.W. Kreutzberg, Microglia in brain tumors. Glia 40, 252–259 (2002)CrossRefPubMed
13.
Zurück zum Zitat R.D. Leek, A.L. Harris, Tumor-associated macrophages in breast cancer. J. Mammary Gland Biol. Neoplasia 7, 177–189 (2002)CrossRefPubMed R.D. Leek, A.L. Harris, Tumor-associated macrophages in breast cancer. J. Mammary Gland Biol. Neoplasia 7, 177–189 (2002)CrossRefPubMed
14.
Zurück zum Zitat N.A. Charles, E.C. Holland, R. Gilbertson, R. Glass, H. Kettenmann, The brain tumor microenvironment. Glia 60, 502–514 (2012)CrossRefPubMed N.A. Charles, E.C. Holland, R. Gilbertson, R. Glass, H. Kettenmann, The brain tumor microenvironment. Glia 60, 502–514 (2012)CrossRefPubMed
15.
Zurück zum Zitat C.E. Green, T. Liu, V. Montel, G. Hsiao, R.D. Lester, S. Subramaniam, S.L. Gonias, R.L. Klemke, Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization. PLoS One 4, e6713 (2009)CrossRefPubMedPubMedCentral C.E. Green, T. Liu, V. Montel, G. Hsiao, R.D. Lester, S. Subramaniam, S.L. Gonias, R.L. Klemke, Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization. PLoS One 4, e6713 (2009)CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat N.B. Hao, M.H. Lu, Y.H. Fan, Y.L. Cao, Z.R. Zhang, S.M. Yang, Macrophages in tumor microenvironments and the progression of tumors. Clin. Dev. Immunol. 2012, 948098 (2012)CrossRefPubMedPubMedCentral N.B. Hao, M.H. Lu, Y.H. Fan, Y.L. Cao, Z.R. Zhang, S.M. Yang, Macrophages in tumor microenvironments and the progression of tumors. Clin. Dev. Immunol. 2012, 948098 (2012)CrossRefPubMedPubMedCentral
17.
18.
Zurück zum Zitat E.M. Dijkgraaf, M. Heusinkveld, B. Tummers, L.T. Vogelpoel, R. Goedemans, V. Jha, J.W. Nortier, M.J. Welters, J.R. Kroep, S.H. van der Burg, Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. Cancer Res. 73, 2480–2492 (2013)CrossRefPubMed E.M. Dijkgraaf, M. Heusinkveld, B. Tummers, L.T. Vogelpoel, R. Goedemans, V. Jha, J.W. Nortier, M.J. Welters, J.R. Kroep, S.H. van der Burg, Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. Cancer Res. 73, 2480–2492 (2013)CrossRefPubMed
19.
Zurück zum Zitat K. Lolmede, L. Campana, M. Vezzoli, L. Bosurgi, R. Tonlorenzi, E. Clementi, M.E. Bianchi, G. Cossu, A.A. Manfredi, S. Brunelli, P. Rovere-Querini, Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J. Leukoc. Biol. 85, 779–787 (2009)CrossRefPubMed K. Lolmede, L. Campana, M. Vezzoli, L. Bosurgi, R. Tonlorenzi, E. Clementi, M.E. Bianchi, G. Cossu, A.A. Manfredi, S. Brunelli, P. Rovere-Querini, Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J. Leukoc. Biol. 85, 779–787 (2009)CrossRefPubMed
20.
Zurück zum Zitat S. Bao, Q. Wu, S. Sathornsumetee, Y. Hao, Z. Li, A.B. Hjelmeland, Q. Shi, R.E. McLendon, D.D. Bigner, J.N. Rich, Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 66, 7843–7848 (2006)CrossRefPubMed S. Bao, Q. Wu, S. Sathornsumetee, Y. Hao, Z. Li, A.B. Hjelmeland, Q. Shi, R.E. McLendon, D.D. Bigner, J.N. Rich, Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 66, 7843–7848 (2006)CrossRefPubMed
21.
Zurück zum Zitat Y. Piao, J. Liang, L. Holmes, A.J. Zurita, V. Henry, J.V. Heymach, J.F. de Groot, Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro-Oncology 14, 1379–1392 (2012)CrossRefPubMedPubMedCentral Y. Piao, J. Liang, L. Holmes, A.J. Zurita, V. Henry, J.V. Heymach, J.F. de Groot, Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro-Oncology 14, 1379–1392 (2012)CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat J. Yang, D. Liao, C. Chen, Y. Liu, T.H. Chuang, R. Xiang, D. Markowitz, R.A. Reisfeld, Y. Luo, Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Stem Cells 31, 248–258 (2013)CrossRefPubMed J. Yang, D. Liao, C. Chen, Y. Liu, T.H. Chuang, R. Xiang, D. Markowitz, R.A. Reisfeld, Y. Luo, Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Stem Cells 31, 248–258 (2013)CrossRefPubMed
23.
Zurück zum Zitat J.J. Watters, J.M. Schartner, B. Badie, Microglia function in brain tumors. J. Neurosci. Res. 81, 447–455 (2005)CrossRefPubMed J.J. Watters, J.M. Schartner, B. Badie, Microglia function in brain tumors. J. Neurosci. Res. 81, 447–455 (2005)CrossRefPubMed
24.
Zurück zum Zitat O.A. Guryanova, Q. Wu, L. Cheng, J.D. Lathia, Z. Huang, J. Yang, J. MacSwords, C.E. Eyler, R.E. McLendon, J.M. Heddleston, W. Shou, D. Hambardzumyan, J. Lee, A.B. Hjelmeland, A.E. Sloan, M. Bredel, G.R. Stark, J.N. Rich, S. Bao, Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 19, 498–511 (2011)CrossRefPubMedPubMedCentral O.A. Guryanova, Q. Wu, L. Cheng, J.D. Lathia, Z. Huang, J. Yang, J. MacSwords, C.E. Eyler, R.E. McLendon, J.M. Heddleston, W. Shou, D. Hambardzumyan, J. Lee, A.B. Hjelmeland, A.E. Sloan, M. Bredel, G.R. Stark, J.N. Rich, S. Bao, Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 19, 498–511 (2011)CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat C.L. Nilsson, R. Dillon, A. Devakumar, S.D. Shi, M. Greig, J.C. Rogers, B. Krastins, M. Rosenblatt, G. Kilmer, M. Major, B.J. Kaboord, D. Sarracino, T. Rezai, A. Prakash, M. Lopez, Y. Ji, W. Priebe, F.F. Lang, H. Colman, C.A. Conrad, Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: An initial study in GSC11 glioblastoma stem cells. J. Proteome Res. 9, 430–443 (2010)CrossRefPubMed C.L. Nilsson, R. Dillon, A. Devakumar, S.D. Shi, M. Greig, J.C. Rogers, B. Krastins, M. Rosenblatt, G. Kilmer, M. Major, B.J. Kaboord, D. Sarracino, T. Rezai, A. Prakash, M. Lopez, Y. Ji, W. Priebe, F.F. Lang, H. Colman, C.A. Conrad, Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: An initial study in GSC11 glioblastoma stem cells. J. Proteome Res. 9, 430–443 (2010)CrossRefPubMed
26.
Zurück zum Zitat H. Wang, J.D. Lathia, Q. Wu, J. Wang, Z. Li, J.M. Heddleston, C.E. Eyler, J. Elderbroom, J. Gallagher, J. Schuschu, J. MacSwords, Y. Cao, R.E. McLendon, X.F. Wang, A.B. Hjelmeland, J.N. Rich, Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells 27, 2393–2404 (2009)CrossRefPubMedPubMedCentral H. Wang, J.D. Lathia, Q. Wu, J. Wang, Z. Li, J.M. Heddleston, C.E. Eyler, J. Elderbroom, J. Gallagher, J. Schuschu, J. MacSwords, Y. Cao, R.E. McLendon, X.F. Wang, A.B. Hjelmeland, J.N. Rich, Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells 27, 2393–2404 (2009)CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat D.J. Brat, A.C. Bellail, E.G. Van Meir, The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-Oncology 7, 122–133 (2005)CrossRefPubMedPubMedCentral D.J. Brat, A.C. Bellail, E.G. Van Meir, The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-Oncology 7, 122–133 (2005)CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat A. Wu, J. Wei, L.Y. Kong, Y. Wang, W. Priebe, W. Qiao, R. Sawaya, A.B. Heimberger, Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro-Oncology 12, 1113–1125 (2010)CrossRefPubMedPubMedCentral A. Wu, J. Wei, L.Y. Kong, Y. Wang, W. Priebe, W. Qiao, R. Sawaya, A.B. Heimberger, Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro-Oncology 12, 1113–1125 (2010)CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat H. Zhang, W. Zhang, X. Sun, R. Dang, R. Zhou, H. Bai, J. Ben, X. Zhu, Y. Zhang, Q. Yang, Y. Xu, Q. Chen, Class A1 scavenger receptor modulates glioma progression by regulating M2-like tumor-associated macrophage polarization. Oncotarget 7, 50099–50116 (2016)CrossRefPubMedPubMedCentral H. Zhang, W. Zhang, X. Sun, R. Dang, R. Zhou, H. Bai, J. Ben, X. Zhu, Y. Zhang, Q. Yang, Y. Xu, Q. Chen, Class A1 scavenger receptor modulates glioma progression by regulating M2-like tumor-associated macrophage polarization. Oncotarget 7, 50099–50116 (2016)CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat J.J. Letterio, A.B. Roberts, Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16, 137–161 (1998)CrossRefPubMed J.J. Letterio, A.B. Roberts, Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16, 137–161 (1998)CrossRefPubMed
31.
Zurück zum Zitat L. Gao, F. Li, B. Dong, J. Zhang, Y. Rao, Y. Cong, B. Mao, X. Chen, Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells. Int. J. Radiat. Oncol. Biol. Phys. 77, 1223–1231 (2010)CrossRefPubMed L. Gao, F. Li, B. Dong, J. Zhang, Y. Rao, Y. Cong, B. Mao, X. Chen, Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells. Int. J. Radiat. Oncol. Biol. Phys. 77, 1223–1231 (2010)CrossRefPubMed
32.
Zurück zum Zitat Y. Liu, C. Li, J. Lin, STAT3 as a therapeutic target for glioblastoma. Anti Cancer Agents Med. Chem. 10, 512–519 (2010)CrossRef Y. Liu, C. Li, J. Lin, STAT3 as a therapeutic target for glioblastoma. Anti Cancer Agents Med. Chem. 10, 512–519 (2010)CrossRef
33.
Zurück zum Zitat D.S. Markovic, R. Glass, M. Synowitz, N. Rooijen, H. Kettenmann, Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J. Neuropathol. Exp. Neurol. 64, 754–762 (2005)CrossRefPubMed D.S. Markovic, R. Glass, M. Synowitz, N. Rooijen, H. Kettenmann, Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J. Neuropathol. Exp. Neurol. 64, 754–762 (2005)CrossRefPubMed
34.
Zurück zum Zitat C. Gedye, L. Ailles, Isolation and characterization of cancer stem cells in vitro. Methods Mol. Biol. 946, 181–204 (2013)CrossRefPubMed C. Gedye, L. Ailles, Isolation and characterization of cancer stem cells in vitro. Methods Mol. Biol. 946, 181–204 (2013)CrossRefPubMed
35.
Zurück zum Zitat S.C. Yu, Y.F. Ping, L. Yi, Z.H. Zhou, J.H. Chen, X.H. Yao, L. Gao, J.M. Wang, X.W. Bian, Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett. 265, 124–134 (2008)CrossRefPubMed S.C. Yu, Y.F. Ping, L. Yi, Z.H. Zhou, J.H. Chen, X.H. Yao, L. Gao, J.M. Wang, X.W. Bian, Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett. 265, 124–134 (2008)CrossRefPubMed
36.
Zurück zum Zitat D.R. Laks, M. Masterman-Smith, K. Visnyei, B. Angenieux, N.M. Orozco, I. Foran, W.H. Yong, H.V. Vinters, L.M. Liau, J.A. Lazareff, P.S. Mischel, T.F. Cloughesy, S. Horvath, H.I. Kornblum, Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells 27, 980–987 (2009)CrossRefPubMedPubMedCentral D.R. Laks, M. Masterman-Smith, K. Visnyei, B. Angenieux, N.M. Orozco, I. Foran, W.H. Yong, H.V. Vinters, L.M. Liau, J.A. Lazareff, P.S. Mischel, T.F. Cloughesy, S. Horvath, H.I. Kornblum, Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells 27, 980–987 (2009)CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat K. Visnyei, H. Onodera, R. Damoiseaux, K. Saigusa, S. Petrosyan, D. De Vries, D. Ferrari, J. Saxe, E.H. Panosyan, M. Masterman-Smith, J. Mottahedeh, K.A. Bradley, J. Huang, C. Sabatti, I. Nakano, H.I. Kornblum, A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells. Mol. Cancer Ther. 10, 1818–1828 (2011)CrossRefPubMedPubMedCentral K. Visnyei, H. Onodera, R. Damoiseaux, K. Saigusa, S. Petrosyan, D. De Vries, D. Ferrari, J. Saxe, E.H. Panosyan, M. Masterman-Smith, J. Mottahedeh, K.A. Bradley, J. Huang, C. Sabatti, I. Nakano, H.I. Kornblum, A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells. Mol. Cancer Ther. 10, 1818–1828 (2011)CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat A. Gray, T. Maguire, R. Schloss, M.L. Yarmush, Identification of IL-1beta and LPS as optimal activators of monolayer and alginate-encapsulated mesenchymal stromal cell immunomodulation using design of experiments and statistical methods. Biotechnol. Prog. 31, 1058–1070 (2015)CrossRefPubMed A. Gray, T. Maguire, R. Schloss, M.L. Yarmush, Identification of IL-1beta and LPS as optimal activators of monolayer and alginate-encapsulated mesenchymal stromal cell immunomodulation using design of experiments and statistical methods. Biotechnol. Prog. 31, 1058–1070 (2015)CrossRefPubMed
39.
Zurück zum Zitat S.S. Hamed, C.M. Roth, Mathematical modeling to distinguish cell cycle arrest and cell killing in chemotherapeutic concentration response curves. J. Pharmacokinet. Pharmacodyn. 38, 385–403 (2011)CrossRefPubMed S.S. Hamed, C.M. Roth, Mathematical modeling to distinguish cell cycle arrest and cell killing in chemotherapeutic concentration response curves. J. Pharmacokinet. Pharmacodyn. 38, 385–403 (2011)CrossRefPubMed
40.
Zurück zum Zitat S. Bao, Q. Wu, R.E. McLendon, Y. Hao, Q. Shi, A.B. Hjelmeland, M.W. Dewhirst, D.D. Bigner, J.N. Rich, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756–760 (2006)CrossRefPubMed S. Bao, Q. Wu, R.E. McLendon, Y. Hao, Q. Shi, A.B. Hjelmeland, M.W. Dewhirst, D.D. Bigner, J.N. Rich, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756–760 (2006)CrossRefPubMed
41.
Zurück zum Zitat J. Wei, J. Barr, L.Y. Kong, Y. Wang, A. Wu, A.K. Sharma, J. Gumin, V. Henry, H. Colman, R. Sawaya, F.F. Lang, A.B. Heimberger, Glioma-associated cancer-initiating cells induce immunosuppression. Clin. Cancer Res. 16, 461–473 (2010)CrossRefPubMedPubMedCentral J. Wei, J. Barr, L.Y. Kong, Y. Wang, A. Wu, A.K. Sharma, J. Gumin, V. Henry, H. Colman, R. Sawaya, F.F. Lang, A.B. Heimberger, Glioma-associated cancer-initiating cells induce immunosuppression. Clin. Cancer Res. 16, 461–473 (2010)CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat L. Benayoun and Y. Shaked, In vitro enrichment of tumor-initiating cells from human established cell lines. Curr. Protoc. Stem Cell Biol. Chapter 3, Unit 3.7 (2013) L. Benayoun and Y. Shaked, In vitro enrichment of tumor-initiating cells from human established cell lines. Curr. Protoc. Stem Cell Biol. Chapter 3, Unit 3.7 (2013)
43.
Zurück zum Zitat E.H. Panosyan, D.R. Laks, M. Masterman-Smith, J. Mottahedeh, W.H. Yong, T.F. Cloughesy, J.A. Lazareff, P.S. Mischel, T.B. Moore, H.I. Kornblum, Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formation. Pediatr. Blood Cancer 55, 644–651 (2010)CrossRefPubMedPubMedCentral E.H. Panosyan, D.R. Laks, M. Masterman-Smith, J. Mottahedeh, W.H. Yong, T.F. Cloughesy, J.A. Lazareff, P.S. Mischel, T.B. Moore, H.I. Kornblum, Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formation. Pediatr. Blood Cancer 55, 644–651 (2010)CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat L. Yi, H. Xiao, M. Xu, X. Ye, J. Hu, F. Li, M. Li, C. Luo, S. Yu, X. Bian, H. Feng, Glioma-initiating cells: A predominant role in microglia/macrophages tropism to glioma. J. Neuroimmunol. 232, 75–82 (2011)CrossRefPubMed L. Yi, H. Xiao, M. Xu, X. Ye, J. Hu, F. Li, M. Li, C. Luo, S. Yu, X. Bian, H. Feng, Glioma-initiating cells: A predominant role in microglia/macrophages tropism to glioma. J. Neuroimmunol. 232, 75–82 (2011)CrossRefPubMed
45.
Zurück zum Zitat Y. Komohara, H. Horlad, K. Ohnishi, Y. Fujiwara, B. Bai, T. Nakagawa, S. Suzu, H. Nakamura, J. Kuratsu, M. Takeya, Importance of direct macrophage-tumor cell interaction on progression of human glioma. Cancer Sci. 103, 2165–2172 (2012)CrossRefPubMed Y. Komohara, H. Horlad, K. Ohnishi, Y. Fujiwara, B. Bai, T. Nakagawa, S. Suzu, H. Nakamura, J. Kuratsu, M. Takeya, Importance of direct macrophage-tumor cell interaction on progression of human glioma. Cancer Sci. 103, 2165–2172 (2012)CrossRefPubMed
46.
Zurück zum Zitat T.O. Jensen, H. Schmidt, H.J. Moller, M. Hoyer, M.B. Maniecki, P. Sjoegren, I.J. Christensen, T. Steiniche, Macrophage markers in serum and tumor have prognostic impact in American joint committee on cancer stage I/II melanoma. J. Clin. Oncol. 27, 3330–3337 (2009)CrossRefPubMed T.O. Jensen, H. Schmidt, H.J. Moller, M. Hoyer, M.B. Maniecki, P. Sjoegren, I.J. Christensen, T. Steiniche, Macrophage markers in serum and tumor have prognostic impact in American joint committee on cancer stage I/II melanoma. J. Clin. Oncol. 27, 3330–3337 (2009)CrossRefPubMed
47.
Zurück zum Zitat H. Kurahara, H. Shinchi, Y. Mataki, K. Maemura, H. Noma, F. Kubo, M. Sakoda, S. Ueno, S. Natsugoe, S. Takao, Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J. Surg. Res. 167, e211–e219 (2011)CrossRefPubMed H. Kurahara, H. Shinchi, Y. Mataki, K. Maemura, H. Noma, F. Kubo, M. Sakoda, S. Ueno, S. Natsugoe, S. Takao, Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J. Surg. Res. 167, e211–e219 (2011)CrossRefPubMed
48.
Zurück zum Zitat D. Niino, Y. Komohara, T. Murayama, R. Aoki, Y. Kimura, K. Hashikawa, J. Kiyasu, M. Takeuchi, N. Suefuji, Y. Sugita, M. Takeya, K. Ohshima, Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL). Pathol. Int. 60, 278–283 (2010)CrossRefPubMed D. Niino, Y. Komohara, T. Murayama, R. Aoki, Y. Kimura, K. Hashikawa, J. Kiyasu, M. Takeuchi, N. Suefuji, Y. Sugita, M. Takeya, K. Ohshima, Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL). Pathol. Int. 60, 278–283 (2010)CrossRefPubMed
49.
Zurück zum Zitat C. Steidl, T. Lee, S.P. Shah, P. Farinha, G. Han, T. Nayar, A. Delaney, S.J. Jones, J. Iqbal, D.D. Weisenburger, M.A. Bast, A. Rosenwald, H.K. Muller-Hermelink, L.M. Rimsza, E. Campo, J. Delabie, R.M. Braziel, J.R. Cook, R.R. Tubbs, E.S. Jaffe, G. Lenz, J.M. Connors, L.M. Staudt, W.C. Chan, R.D. Gascoyne, Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N. Engl. J. Med. 362, 875–885 (2010)CrossRefPubMedPubMedCentral C. Steidl, T. Lee, S.P. Shah, P. Farinha, G. Han, T. Nayar, A. Delaney, S.J. Jones, J. Iqbal, D.D. Weisenburger, M.A. Bast, A. Rosenwald, H.K. Muller-Hermelink, L.M. Rimsza, E. Campo, J. Delabie, R.M. Braziel, J.R. Cook, R.R. Tubbs, E.S. Jaffe, G. Lenz, J.M. Connors, L.M. Staudt, W.C. Chan, R.D. Gascoyne, Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N. Engl. J. Med. 362, 875–885 (2010)CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat A. Sica, T. Schioppa, A. Mantovani, P. Allavena, Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717–727 (2006)CrossRefPubMed A. Sica, T. Schioppa, A. Mantovani, P. Allavena, Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717–727 (2006)CrossRefPubMed
51.
Zurück zum Zitat J. Lee, S. Kotliarova, Y. Kotliarov, A. Li, Q. Su, N.M. Donin, S. Pastorino, B.W. Purow, N. Christopher, W. Zhang, J.K. Park, H.A. Fine, Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391–403 (2006)CrossRefPubMed J. Lee, S. Kotliarova, Y. Kotliarov, A. Li, Q. Su, N.M. Donin, S. Pastorino, B.W. Purow, N. Christopher, W. Zhang, J.K. Park, H.A. Fine, Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391–403 (2006)CrossRefPubMed
52.
Zurück zum Zitat X.Z. Ye, S.L. Xu, Y.H. Xin, S.C. Yu, Y.F. Ping, L. Chen, H.L. Xiao, B. Wang, L. Yi, Q.L. Wang, X.F. Jiang, L. Yang, P. Zhang, C. Qian, Y.H. Cui, X. Zhang, X.W. Bian, Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J. Immunol. 189, 444–453 (2012)CrossRefPubMed X.Z. Ye, S.L. Xu, Y.H. Xin, S.C. Yu, Y.F. Ping, L. Chen, H.L. Xiao, B. Wang, L. Yi, Q.L. Wang, X.F. Jiang, L. Yang, P. Zhang, C. Qian, Y.H. Cui, X. Zhang, X.W. Bian, Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J. Immunol. 189, 444–453 (2012)CrossRefPubMed
53.
Zurück zum Zitat Z.G. Ouedraogo, J. Biau, J.L. Kemeny, L. Morel, P. Verrelle, E. Chautard, Role of STAT3 in genesis and progression of human malignant gliomas. Mol. Neurobiol. (2016). doi:10.1007/s12035-016-0103-0 Z.G. Ouedraogo, J. Biau, J.L. Kemeny, L. Morel, P. Verrelle, E. Chautard, Role of STAT3 in genesis and progression of human malignant gliomas. Mol. Neurobiol. (2016). doi:10.​1007/​s12035-016-0103-0
54.
Zurück zum Zitat K.M. Talasila, G.V. Rosland, H.R. Hagland, E. Eskilsson, I.H. Flones, S. Fritah, F. Azuaje, N. Atai, P.N. Harter, M. Mittelbronn, M. Andersen, J.V. Joseph, J.A. Hossain, L. Vallar, C.J. Noorden, S.P. Niclou, F. Thorsen, K.J. Tronstad, C. Tzoulis, R. Bjerkvig, H. Miletic, The angiogenic switch leads to a metabolic shift in human glioblastoma. Neuro. Oncol. 19, 383–393 (2016) K.M. Talasila, G.V. Rosland, H.R. Hagland, E. Eskilsson, I.H. Flones, S. Fritah, F. Azuaje, N. Atai, P.N. Harter, M. Mittelbronn, M. Andersen, J.V. Joseph, J.A. Hossain, L. Vallar, C.J. Noorden, S.P. Niclou, F. Thorsen, K.J. Tronstad, C. Tzoulis, R. Bjerkvig, H. Miletic, The angiogenic switch leads to a metabolic shift in human glioblastoma. Neuro. Oncol. 19, 383–393 (2016)
55.
Zurück zum Zitat C. Villalva, S. Martin-Lanneree, U. Cortes, F. Dkhissi, M. Wager, A. Le Corf, J.M. Tourani, I. Dusanter-Fourt, A.G. Turhan, L. Karayan-Tapon, STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: A potential for targeted therapy? Int. J. Cancer 128, 826–838 (2011)CrossRefPubMed C. Villalva, S. Martin-Lanneree, U. Cortes, F. Dkhissi, M. Wager, A. Le Corf, J.M. Tourani, I. Dusanter-Fourt, A.G. Turhan, L. Karayan-Tapon, STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: A potential for targeted therapy? Int. J. Cancer 128, 826–838 (2011)CrossRefPubMed
56.
Zurück zum Zitat M.W. Roomi, T. Kalinovsky, M. Rath, A. Niedzwiecki, Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells. Oncol. Rep. 37, 1907–1913 (2017)CrossRefPubMed M.W. Roomi, T. Kalinovsky, M. Rath, A. Niedzwiecki, Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells. Oncol. Rep. 37, 1907–1913 (2017)CrossRefPubMed
57.
Zurück zum Zitat M.W. Roomi, T. Kalinovsky, J. Monterrey, M. Rath, A. Niedzwiecki, In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors. Int. J. Oncol. 43, 1787–1798 (2013)CrossRefPubMedPubMedCentral M.W. Roomi, T. Kalinovsky, J. Monterrey, M. Rath, A. Niedzwiecki, In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors. Int. J. Oncol. 43, 1787–1798 (2013)CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat E.S. Kim, Y.E. Choi, S.J. Hwang, Y.H. Han, M.J. Park, I.H. Bae, IL-4, a direct target of miR-340/429, is involved in radiation-induced aggressive tumor behavior in human carcinoma cells. Oncotarget 7, 86836–86856 (2016)PubMedPubMedCentral E.S. Kim, Y.E. Choi, S.J. Hwang, Y.H. Han, M.J. Park, I.H. Bae, IL-4, a direct target of miR-340/429, is involved in radiation-induced aggressive tumor behavior in human carcinoma cells. Oncotarget 7, 86836–86856 (2016)PubMedPubMedCentral
Metadaten
Titel
Crosstalk between M2 macrophages and glioma stem cells
verfasst von
Leora M. Nusblat
Molly J. Carroll
Charles M. Roth
Publikationsdatum
22.06.2017
Verlag
Springer Netherlands
Erschienen in
Cellular Oncology / Ausgabe 5/2017
Print ISSN: 2211-3428
Elektronische ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-017-0337-5

Weitere Artikel der Ausgabe 5/2017

Cellular Oncology 5/2017 Zur Ausgabe

Neu im Fachgebiet Pathologie